| MT 2164 Adenylosuccinic acid, [3H]- | |
|
HPLC
purified, Delivered ≥ 93% pure with dated HPLC radiochromatogram
|
|
| Aqueous solution, 100 mCi/ml | |
| ≥ 3 Ci(111 GBq)/mmol | 50 µCi (1.85 MBq) $1160 |
| NextGen V-Vial | 250 µCi (9.25 MBq) $1970 |
|
M.W. 463.3  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |